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Background: The management of acute calculous cholecystitis still offers room for debate in terms of diagnosis,
severity scores, treatment options and timing for surgery.
Material and methods: A systematic review about the treatment of acute cholecystitis has been completed. The
recommendations of recent guidelines have also been examined taking into account the results of the review.
Results: The evidence available in the literature supports the recommendation about laparoscopic cholecystectomy
as treatment of choice for acute cholecystitis. Surgery should be performed as soon as possible after the diagnosis
because early treatment reduces total hospital stay and does not increase complication or conversion rates. The
antibiotics can play different roles and attention should be posed to the risk of emerging resistance. A surgical or
percutaneous drainage of the gallbladder is advocated by some authors in the advanced forms of inflammation or
patients with severe co-morbidities; however, the available evidence does not support it, and further studies are
necessary to clarify its role.Introduction
The literature about the treatment of acute calculous
cholecystitis has been recently examined in more than one
Consensus Conference [1-3]. The disease could present
with a picture ranging from mild, self-limiting, to a poten-
tially life-threatening illness, and the severity of inflamma-
tion and its life-threatening potential is also strongly
determined by the general condition of the patient. The
degree of inflammation of the gallbladder and the condi-
tions of patients with their co-morbidities contribute to
indicate the best therapeutic option for every single
patient. However, such heterogeneity makes very difficult
to standardize a therapeutic protocol for this condition.
The optimal surgical treatment for acute cholecystitis
should be examined according to its severity; however,
no uniform grading system is yet available, and the need
for practical patient-related operative guidelines has
been stressed elsewhere [4].
Even the evidences about the outcome of the thera-
peutic procedures adopted are difficult to evaluate in this
heterogeneous context; studies available have not generally
examined the optimal treatment for acute cholecystitis* Correspondence: campanile@surgical.net
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article, unless otherwise stated.according to its severity. A systematic review of the litera-
ture must take into consideration this aspect.
The literature review has been presented to the 2nd
World Society for Emergency Surgery held in Bergamo
in July 2013. This position paper follows the indication
emerged in that meeting.Review of literature
The results of the systematic literature review performed
for the EAES Consensus Conference about the laparo-
scopic approach to the acute abdomen, published in 2012
were entirely considered for this analysis; the literature
search strategy adopted has been detailed in that paper [1].
An additional literature search was done from 2010
through February 2013 with the following limits and
filters: adult, clinical trial, review and english language.
The PICO (population, intervention, comparison, out-
come) system was applied for the MeSH (Medical Sub-
ject Headings) search whenever possible. Analogous
search has covered the Cochrane Collaboration database
and the Google Scholar in order to gather all the
remaining evidence, synopses and guidelines on the topic.
The following search string was used:
(“cholecystitis, acute”[MeSH Terms] OR (“cholecystitis”
[All Fields] AND “acute”[All Fields]) OR “acute cholecystitis”
[All Fields] OR (“acute”[All Fields] AND “cholecystitis”[Alltral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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AND (“2010/01/01”[PDAT]: “2013/12/31”[PDAT]) AND
“humans”[MeSH Terms] AND English [lang]).
A total of 79 citations was identified.
A search without the limits “clinical trial” and “review”
was then carried out, obtaining 392 additional papers
whose abstracts were examined for relevance. Two
authors (FCC and MP) collected data independently.
After exclusion of duplicates, publications with no
abstract and of low interest in the specific topics and key
questions, 77 publications were taken into consideration:
The papers have been classified for evidence strength
following the Oxford CEBM 2011 scheme. In the rest of
this paper, the level of evidence obtained has been speci-
fied after every relevant reference citation as evidence
level (EL) 1–5.
The literature obtained has also been used to update
the results of the above cited Consensus Conference.
This update has been presented at the 32nd “Congresso
Nazionale ACOI” held in Florence (Italy) in May 2013.
For the purpose of publication, the search was extended
to April 2014.
Timing of surgery
The issue of early versus delayed laparoscopic cholecyst-
ectomy for acute cholecystitis is examined in seven
randomized controlled trials [5-11] and 5 meta-analyses
(EL1) [12-17]. The studies show that an early treatment
reduces total hospital stay and does not increase compli-
cation or conversion rates. In particular, the rate of bile
duct injury has been shown to be higher in the delayed
treated patients, but the difference was not statistically
significant due to the small numbers analyzed in the
trials.
The optimal delay for surgery after the onset of symp-
toms it is not completely clarified in the above men-
tioned studies and deserves a more precise definition.
One of the systematic reviews examined above [10,12]
performed a subgroup analysis and could not demon-
strate a statistically significant difference between the
patients treated less than four days from the onset of
symptoms and those of the studies also including pa-
tients with a longer delay. One large population-based
studies, mentioned above, examined the risk-adjusted as-
sociation between outcomes and preoperative length of
hospital stay (used as a proxy for the onset of symptoms).
There was no significant association between preoperative
length of stay and 30-day postoperative mortality or over-
all morbidity. However, patients hospitalized for two or
more days preoperatively sustained longer operative times
and were significantly more likely to require open chole-
cystectomy compared with patients who received oper-
ation on the day of admission [18]. The above mentioned
evidence supported the EAES Consensus Conference torecommend early cholecystectomy for acute cholecystitis,
and to state that surgery should be performed as soon as
possible after the onset of symptoms.
On the contrary, the authors of the Tokyo guidelines
maintain that, despite the demonstration that early
cholecystectomy is indicated for acute cholecystitis in an
unselected population, still it could be possible to im-
prove the overall outcome of this condition tailoring the
treatment according to the severity of the condition and
to the patient status. They suggest a staging system based
upon severity assessment criteria such as degree of local
inflammation and patient conditions. According to their
classification acute cholecystitis is defined as “severe
(grade III)” if associated with organ dysfunction, “moder-
ate (grade II)” if the completion of a cholecystectomy is
likely to be difficult due to local inflammation (“criteria
predicting when conditions might be unfavorable for
cholecystectomy in the acute phase”), and “mild (grade I)”
if it does not meet the criteria for grade II or III [19-21].
Based on that scheme, the Tokyo guidelines suggest
early laparoscopic cholecystectomy only in the mild
forms of the disease (grade I), in which a laparoscopic
cholecystectomy is likely to be easy. In the moderate
cases, medical therapy with or without early gallbladder
drainage (surgical or percutaneous) followed by delayed
cholecystectomy is indicated, except in “experienced”
centers. The “severe” grade (with organ dysfunction) is
trusted to cholecystostomy.
However, several reports show that early cholecystec-
tomy is safe even in the severe forms of the disease
[22-24] or in the elderly population [25-27]. In particu-
lar, a recent review of prospective and retrospective
series (EL3) [28] did not show an increase in local
postoperative complications in severe cholecystitis and
confirmed that laparoscopic cholecystectomy is to be
considered an acceptable indication for it, despite a
demonstrated threefold conversion rate.
Laparoscopic vs open cholecystectomy
There are two randomized trials (EL2) [29,30], a population-
based outcome research (EL3) [31] and numerous com-
parative studies demonstrating that laparoscopic chole-
cystectomy is associated with faster recovery and shorter
hospital stay than open cholecystectomy; the population-
based outcome research showed also lower morbidity
and mortality [31]. This evidence supported the EAES
Consensus Conference recommendation that laparo-
scopic cholecystectomy be the treatment of choice for
acute cholecystitis.
The preference for laparoscopic cholecystectomy is
also expressed in the Tokyo guidelines [3]; however, the
“severity” tailored approach suggested in those guide-
lines limits the indication for surgery only to the mildest
forms of acute cholecystitis and takes in consideration
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mentioned above, specifically included gangrenous chole-
cystitis (to be classified in the “moderate” form according
to the Tokyo guidelines) [29] and a recent meta-analysis
shows that straight laparoscopic cholecystectomy is indi-
cated in severe (gangrenous, empyematous) cholecystitis
(EL3) [28].
Advanced age also does not preclude the indication
for laparoscopic cholecystectomy (EL3) [32-35].
Antibiotic treatment
Different antibiotic regimens can be employed in acute
cholecystitis; the choice must be based on the most
common pathogens, community acquired or health care
associated infections, pharmacodynamics and pharmaco-
kinetics of the antibiotic and evolution of sepsis. More-
over, the antibiotics can be administered with different
intent: as an ancillary role for early surgery or cholecys-
tostomy or as the unique treatment for acute episode in
the non-operative setting and delayed surgery.
The most accredited guidelines arise from TG 2013
and the WSES: the last one is the most updated and take
into consideration also “new drugs” such a Tigecycline
(see Table 1) [36,37].
Percutaneous cholecystostomy (PC)
Percutaneous tube cholecystostomy (followed or not by
surgery) is reported in the literature as an alternative for
the emergency treatment in septic high-risk patients. In
particular, as mentioned above, the Tokyo guidelines
consider the percutaneous (or surgical) drainage as
mandatory in the severe grade of acute cholecystitis and
also suggest its use in the moderate grade, in order to
overcoming the technical difficulties of an inflamed gall-
bladder. However, gallbladder drainage has never been
proven to be an effective alternative to early surgery; the
evidence on its role is still poor. The panel of the Tokyo
Guidelines states that it is known to be an effective op-
tion in critically ill patients, especially in elderly patients
and patients with complications; however, no evidence is
provided to support the statement, and it is recognized
that there have been no randomized controlled trials on
the issue.
As a matter of fact, a Cochrane systematic review
included two trials, and none of them addressed theTable 1 Recommendation for antibiotic strategy in acute cho
Community acquired
Infectious situation Drug I
No Severe Sepsis ESBL - Amox-Clav N
No Severe Sepsis ESBL + Tigecycline
Severe Sepsis ESBL - Pipera-Tazo S
Severe Sepsis ESBL + Pipera-Tazo + Tigecycline + −Fluconazolecomparison of early cholecystectomy vs. percutaneous
cholecystostomy [38].
A recent review performed a particularly detailed exam-
ination of 53 papers about cholecystostomy as an option
in acute cholecystitis (EL3). It found no evidence to sup-
port the recommendation of percutaneous drainage rather
than straight early emergency cholecystectomy even in
critically ill patients. Actually, it suggested that cholecyst-
ectomy seems to be a better option for treating acute
cholecystitis in the elderly and/or critically ill population
[39]. Even if the results obtained from the studies reviewed
are non-homogeneous, the mortality rate after PC (15.4%)
is significantly higher than reported after early cholecyst-
ectomy (4.5%) in published series of similar patients. Of
course, the reports analyzed in the PC group take into
account also patients who could not have tolerated any
surgery, and this limitation has to be considered.
After their review, about 27 further observational stud-
ies have been published, confirming that the groups con-
sidered in the studies, their inclusion criteria, the results
and even the conclusions reached by different authors
are largely non-homogeneous. With these limitations in
mind, the reported in-hospital mortality for cholecys-
tostomy varies between 4 and 50% (vs. 4.5% reported for
cholecystectomy) and its morbidity ranges between 8.2
and 62%.
The role of percutaneous drainage of the gallbladder is
difficult to investigate also because different definitions
are used to identify “high-risk patients”.
At the present time, percutaneous cholecystostomy
cannot be recommended as part of a routine protocol
for treatment of acute cholecystitis, but only considered
as a possible alternative to reduce anesthesiology risk in
a small subset of patients unfit for emergency surgery
due to their severe co-morbidities. A randomized con-
trolled trial (CHOCOLATE Trial) has been planned to
attempt to clarify the largely conflicting evidence [40].
Recommendations
We recommend that laparoscopic cholecystectomy be
considered the treatment of choice for acute cholecyst-
itis and that surgery be performed as soon as possible
after the diagnosis.
The role of antibiotics is relevant both in conservative
therapy of the inflammation or as support to invasivelecystitis (modified from WSES 2013)
Healt care associated
nfectious situation Drug
o Severe Sepsis Pipera-Tazo + Tigecycline + −Fluconazole
evere Sepsis Pipera-Tazo + Tigecicline + Echinocandin or
Carbap Antibiotics + Teicoplanin + Echinocandin
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protocol is necessary to deal with bacterial resistance.
We recommend the use of the 2013 WSES guidelines
because they take into account several new drugs com-
pared to TG13.
At present, we do not recommend that cholecystost-
omy (surgical or percutaneous) be included in routine
protocols for treatment of acute cholecystitis, and we
suggest that it be considered, only in those patient
clearly unfit for emergency surgery, until better evidence
are available.
Discussion
The above reported literature review clarifies the advan-
tages of early laparoscopic cholecystectomy in an unse-
lected population. It has to be stressed, however, that
acute cholecystitis is a very heterogeneous disease as far
as general and local factors are concerned. The severity
of inflammation and its life-threatening potential is
strongly determined by the general status of the patient,
and the choice of surgical treatment cannot disregard
this aspect [4]. Also, the general principles expressed in
the literature have to be applied taking into account the
environment, the socio-economic context in which such
an emergency develops and the related logistics.
The Tokyo guidelines attempted to address such
heterogeneity with the above described classification,
that takes into account both local and general factors,
and a therapeutic protocol based on such scheme.
Such a tailored approach, however, has not been vali-
dated by studies showing an improved outcome after its
introduction, and a retrospective series did not find any
significant benefit [41]. It ends up in a large use of de-
layed cholecystectomy, despite several meta-analysis of
RCTs establish that early laparoscopic cholecystectomy
is to be considered the gold standard. It also disregards
the examined literature about the safety of early laparo-
scopic cholecystectomy in the severe forms of the disease.
Furthermore, the role of percutaneous cholecystostomy is
far from being established as discussed above: its thera-
peutic potential needs to be confirmed by the literature
evidence and integrated in an evidence-based algorithm.
The risk of early surgery for acute cholecystitis should
be evaluated against a well-established risk score in
order to identifying the patients with reduced functional
reserve who should undergo a treatment alternative to
surgery. However, none of the available clinical scores
for the evaluation of surgical risk for acute conditions
[42,43] has been validated for this disease. Further inves-
tigations could help in validating a clinical score useful
for clinical and therapeutic decision making for acute
cholecystitis.
In addition, it has to be stressed that the general prin-
ciples expressed in the evidence based recommendationshave to be adapted to the technical, environmental and
social conditions of the different areas of the world. The
indications suggested by the Tokyo Guidelines, too lim-
ited for most of the Western countries, still have been
shown to increase the adoption of early laparoscopic
cholecystectomy in a Japanese context, as reported by
Asai [44].
In many developing areas complex technology is not
readily available, the diffusion of laparoscopy is still
extremely sparse [45] and percutaneous drainage is not
available. It is still debated if the introduction of minim-
ally invasive surgery is proper in many developing coun-
tries where safe performance cannot always be assured
[46] and economic resources could be better employed
on more essential health programs [47]. The interpret-
ation of our recommendations in those environments
has to take into account that the value of early chole-
cystectomy for acute cholecystitis is supported by a level
of evidence stronger than the laparoscopic approach.
Therefore, in those areas where laparoscopy is not
readily available, an early laparotomic operation may be
preferred to a long transfer to a far away facility, taking
into consideration the local situation, the logistics and
the patient conditions.
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